Issue 16, 2015

Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles

Abstract

We describe for the first time a therapeutic strategy to target stem-like cancer cells via STAT-3 modulation using a nanomedicine approach. Niclocelle, a niclosamide loaded rigid core mixed micelle, was synthesized from a self-assembled well-defined amphiphilic diblock copolymer and an FDA-approved signal transducer and activator of transcription factor 3. Followed by a rigorous physico-chemical characterization, niclocelles were evaluated biologically for cytotoxicity and apoptosis in human melanoma (C32) and breast cancer (MDA-MB231 and MCF-7) cells. Niclocelles were found to selectively reduce the CD44+ stem cell population in C32 cells via STAT-3 modulation.

Graphical abstract: Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles

Supplementary files

Article information

Article type
Communication
Submitted
19 Jan 2015
Accepted
04 Mar 2015
First published
05 Mar 2015

Nanoscale, 2015,7, 7127-7132

Enriched inhibition of cancer and stem-like cancer cells via STAT-3 modulating niclocelles

S. K. Misra, T. W. Jensen and D. Pan, Nanoscale, 2015, 7, 7127 DOI: 10.1039/C5NR00403A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements